CASP2 and acute myeloid leukemia: In primary leukemic mononuclear cells from AML patients, GO treatment in vitro induced the disappearance of the 49 kDa full-length caspase-2 in GO-responsive patient cells but without detection of a cleaved 35 kDa caspase-2 fragment.